Will the price of Mounjaro go down in 2025 in the UK? What the evidence says

The myth: Mounjaro was about to get cheaper in 2025

A lot of readers arrived at this question having seen forum posts or social-media threads predicting a price drop. The logic seemed reasonable: as supply normalises and competition grows, prices should fall. That is how most markets work. The Mounjaro market in 2025 did not follow that script.

In August 2025, Eli Lilly announced a significant list-price increase, widely reported at the time, that came into force on 1 September 2025. The highest-dose pen moved from a list price of roughly £122 to roughly £330. Lower doses saw smaller but still meaningful increases. Private pharmacies and clinics, which buy through the licensed UK supply chain, passed those increases through to their own pricing. If you want a detailed breakdown, our guide covering how much Mounjaro costs in 2025 sets out the figures dose by dose. Typical private prices since September 2025 have ranged roughly £149 to £375 per month depending on the dose and the provider, figures you can cross-check against current listings, though they shift.

The short answer to whether the price went down in 2025: no. If you are curious about whether the price of Mounjaro might go down in 2026, that is a more relevant question to be asking now, and we cover it in detail there. For a fuller picture of where things might go from here, if you are wondering whether the cost of Mounjaro will go down, that is a more relevant question to be asking now.

What headline prices on comparison sites often leave out

When you see a monthly Mounjaro price advertised online, it is worth spending sixty seconds checking what that figure actually covers. Pull up the small print and look for three things: is there a separate consultation or prescription fee? Is delivery included? And is aftercare (dose-review support, access to a prescriber between orders) part of the package or sold as an optional extra?

Across the private market, there is genuine variation. Some providers charge a low headline price and add a consultation fee at checkout. Others include delivery only on the first order. Clinical follow-up, which matters for a medicine that is titrated in stages over months, is sometimes absent entirely, leaving patients to manage dose changes alone. That is a gap worth knowing about before you commit.

None of this is to name or judge competitors. It is consumer education that our FAQs reflect regularly, because questions about pricing structure are among the most common our prescribers field.

How nume prices treatment, and why we are not trying to be cheapest

There is one price at nume. It covers the consultation, the prescription, the medicine, delivery and aftercare. Nothing is added at checkout. We do not run discount codes, promotional vouchers or seasonal sales, for a prescription medicine, that kind of marketing sits awkwardly against the clinical framework the treatment requires.

We are deliberately not the lowest-cost option. That is a choice, not an oversight. What the single price buys is a real prescriber reviewing your answers the same day (and reviewing them again before every repeat), free next-working-day delivery in plain unbranded packaging, and a clinical team available seven days a week if something changes. Current treatment pricing is on the treatment page, we do not print per-pen figures here because prices at any dose can be confirmed there accurately and kept current.

If you want to understand the full cost picture before starting, our Mounjaro pricing guide sets out what private treatment typically costs across the titration schedule, without requiring you to start a consultation first.

Why 'cheapest' is the wrong test for a prescription medicine

A lower price for tirzepatide is only a saving if what arrives is genuine, stored correctly and supplied through the licensed UK supply chain. The MHRA has warned repeatedly about counterfeit weight-loss pens sold online, and enforcement in 2025 included the raid of an illicit manufacturing site producing fake tirzepatide pens. Some seized fakes contained insulin. The price on those was low. The risk was not.

You can verify any online pharmacy in under a minute at the GPhC register, that check costs nothing and is the single most useful thing to do before handing over payment details. If a seller cannot be found there, that is your answer. The MHRA's Yellow Card scheme also lets you report suspect sellers directly.

The more useful question than cheapest is: is this service clinically safe, is the supply chain verified, and does the aftercare match what a titrated prescription medicine actually needs? Those are the tests worth running. If you want to look at how costs have moved more broadly, the Mounjaro prices trajectory page covers the longer trend, and our about page explains how nume is set up and regulated. When you are ready to check whether you are eligible, a free consultation is the starting point.